Know-Legal Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. National drug code - Wikipedia

    en.wikipedia.org/wiki/National_Drug_Code

    The national drug code is a unique 10 or 11 digit, 3-segment numeric identifier assigned to each medication listed under Section 510 of the US Federal Food, Drug, and Cosmetic Act. The segments identify the labeler or vendor, product (within the scope of the labeler), and trade package (of this product). The first segment, the labeler code, is ...

  3. Center for Biologics Evaluation and Research - Wikipedia

    en.wikipedia.org/wiki/Center_for_Biologics...

    The Center for Biologics Evaluation and Research ( CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. CBER is responsible for assuring the safety, purity, potency, and effectiveness of ...

  4. Biologics license application - Wikipedia

    en.wikipedia.org/wiki/Biologics_License_Application

    The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680. A BLA is submitted by any legal person or entity who is engaged in manufacture or an applicant for a license who takes responsibility ...

  5. Marketing authorisation - Wikipedia

    en.wikipedia.org/wiki/Marketing_authorisation

    Marketing authorisation. Marketing authorisation is the process of reviewing and assessing the evidence to support a medicinal product, such as a drug, in relation to its marketing, finalised by granting of a licence to be sold. This process is performed within a legal framework defining the requirements necessary for successful application to ...

  6. CFR - Code of Federal Regulations Title 21

    highline.huffingtonpost.com/miracleindustry/...

    [code of federal regulations] [title 21, volume 5] [revised as of april 1, 2015] [cite: 21cfr314.50] title 21­­food and drugs chapter i­­food and drug administration department of health and human services subchapter d­­drugs for human use part 314 ­­ applications for fda approval to market a new drug

  7. Pharmaceuticals and Medical Devices Agency - Wikipedia

    en.wikipedia.org/wiki/Pharmaceuticals_and...

    Auditing of manufacturers to ensure they conform to Good Manufacturing Practice (GMP) and have a suitable Quality Management System (QMS) Post-marketing drug safety: The collection, analysis and distribution of data on the quality, efficacy, and safety data of medicines and medical devices; Advising consumers on approved products

  8. Unique Ingredient Identifier - Wikipedia

    en.wikipedia.org/wiki/Unique_Ingredient_Identifier

    The Unique Ingredient Identifier ( UNII) is an alphanumeric identifier linked to a substance's molecular structure or descriptive information and is generated by the Global Substance Registration System (GSRS) of the Food and Drug Administration (FDA). It classifies substances as chemical, protein, nucleic acid, polymer, structurally diverse ...

  9. Form FDA 483 - Wikipedia

    en.wikipedia.org/wiki/Form_FDA_483

    Form FDA 483. The U.S. Food and Drug Administration (FDA) is authorized to perform inspections under the Federal Food, Drug, and Cosmetic Act, Sec. 704 (21 USC §374) "Factory Inspection". [1] Form FDA 483, [2] "Inspectional Observations", is a form used by the FDA to document and communicate concerns discovered during these inspections.